Page last updated: 2024-08-23

lidofenin and Obesity, Morbid

lidofenin has been researched along with Obesity, Morbid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arnon-Sheleg, E; Farraj, M; Khoury, T; Mari, A; Michael, S; Sbeit, W1
Frizzi, JD; Gustafson, RJ; Wilkinson, NW1

Trials

1 trial(s) available for lidofenin and Obesity, Morbid

ArticleYear
The effect of erythromycin on bile excretion and proximal small bowel motility following divided gastric bypass surgery: a prospective randomized placebo-controlled trial.
    Obesity surgery, 2002, Volume: 12, Issue:6

    Topics: Bile; Biliary Tract; Double-Blind Method; Duodenum; Erythromycin; Gastric Bypass; Gastrointestinal Agents; Gastrointestinal Motility; Gastrointestinal Transit; Humans; Imino Acids; Liver; Obesity, Morbid; Postoperative Period; Prospective Studies; Radionuclide Imaging

2002

Other Studies

1 other study(ies) available for lidofenin and Obesity, Morbid

ArticleYear
Modified Hepatobiliary Scintigraphy for the Diagnosis of Bile Reflux in One-Anastomosis Gastric Bypass Surgery: a Prospective Multicenter Study.
    Obesity surgery, 2023, Volume: 33, Issue:7

    Topics: Adult; Bile Reflux; Esophagitis; Female; Gastric Bypass; Gastroesophageal Reflux; Humans; Male; Obesity, Morbid; Prospective Studies; Radionuclide Imaging; Reproducibility of Results

2023